Haemonetics Corporation provides medical products and solutions. It operates through three segments: Plasma, Blood Center, and Hospital. The company offers automated plasma collection devices, related disposables, and software. It also provides automated blood component and manual whole blood collection systems.
Market Cap | 4.354 Billion | Shares Outstanding | 51.11 Million | Avg 30-day Volume | 474.189 Thousand |
P/E Ratio | 44.3576 | Dividend Yield | 0.0 | EPS | 1.27 |
Price to Revenue | 3.522 | Debt to Equity | 1.1217 | EBITDA | 210.235 Million |
Price to Book Value | 5.2357 | Operating Margin | 12.2125 | Enterprise Value | 4.393 Billion |
Current Ratio | 2.73 | EPS Growth | 1.767 | Quick Ratio | 1.574 |
1 Yr BETA | 0.8345 | 52-week High/Low | 91.39 / 43.5 | Profit Margin | 7.94 |
Operating Cash Flow Growth | 136.7449 | Altman Z-Score | 3.2425 | Free Cash Flow to Firm | 81.892 Million |
Earnings Report | 2023-02-07 |
Please sign in first
none
2.4 Thousand total shares from 1 transactions
2.4 Thousand total shares from 1 transactions
Insider Name | Type | Last Reported Shares Held | Last Reported Date | Filings in past year |
---|---|---|---|---|
LLORENS JOSEP EVP, GLOBAL MANUFACTURING |
|
24,407 | 2023-01-23 | 4 |
SIMON, CHRISTOPHER PRESIDENT & CEO |
|
205,124 | 2022-11-11 | 4 |
GALVIN ROY PRESIDENT, GLOBAL PLASMA & BC |
|
7,645 | 2022-11-01 | 2 |
STRONG STEWART W PRESIDENT, GLOBAL HOSPITAL |
|
15,681 | 2022-10-24 | 3 |
BASIL MICHELLE L EVP AND GENERAL COUNSEL |
|
32,455 | 2022-10-24 | 6 |
MAUNSELL FARRIS MARYANNE VP, CHIEF ACCOUNTING OFFICER |
|
0 | 2022-10-17 | 1 |
MILLER LAURIE A. SVP, HUMAN RESOURCES |
|
12,697 | 2022-09-19 | 6 |
|
16,231 | 2022-08-15 | 2 | |
|
17,855 | 2022-08-05 | 1 | |
|
8,268 | 2022-08-05 | 1 | |
|
19,545 | 2022-08-05 | 1 | |
|
12,247 | 2022-08-05 | 1 | |
|
28,130 | 2022-08-05 | 1 | |
|
9,746 | 2022-08-05 | 1 | |
|
5,807 | 2022-08-05 | 1 | |
GOLDSTEIN DAN VP, CORPORATE CONTROLLER |
|
4,447 | 2022-06-13 | 4 |
LINGAMNENI ANILA EVP, CHIEF TECHNOLOGY OFFICER |
|
17,322 | 2022-05-19 | 3 |
DARECCA JAMES EVP, CHIEF FINANCIAL OFFICER |
|
21,839 | 2022-05-16 | 3 |
BURKE WILLIAM P. MR. EVP, CHIEF FINANCIAL OFFICER |
|
30,291 | 2021-08-23 | 0 |
NIKEL CHAD M. PRESIDENT, GLOBAL PLASMA & BC |
|
17,336 | 2021-08-06 | 0 |
SCANLAN JACQUELINE SVP, GLOBAL HUMAN RESOURCES |
|
4,216 | 2021-06-07 | 0 |
|
32,050 | 2021-02-04 | 0 | |
|
48,384 | 2019-11-11 | 0 | |
BOLORFOROSH SAID EVP, CHIEF TECHNOLOGY OFFICER |
|
1,977 | 2019-11-11 | 0 |
|
15,335 | 2018-11-08 | 0 | |
RYDING NEIL MR. EVP, GLOBAL MANUFACTURING |
|
15,226 | 2018-06-07 | 0 |
|
20,740 | 2017-11-10 | 0 | |
|
17,807 | 2017-05-22 | 0 | |
JESSE SANDRA EVP AND CHIEF LEGAL OFFICER |
|
48,166 | 2016-10-25 | 0 |
SELMAN BYRON PRESIDENT, GLOBAL MARKETS |
|
23,318 | 2016-10-25 | 0 |
FUSCO DAVID EVP, GLOBAL HUMAN RESOURCES |
|
16,867 | 2016-10-25 | 0 |
LINDOP CHRISTOPHER J CFO & EVP BUSINESS DEVELOPMENT |
|
56,743 | 2016-01-13 | 0 |
HANLON SUSAN M VP FINANCE |
|
20,464 | 2015-10-26 | 0 |
WHITE JONATHAN CHIEF SCIENCE AND TECHNOLOGY |
|
30,507 | 2015-10-26 | 0 |
BURNS BRIAN R EVP, GLOBAL QA/RA |
|
16,235 | 2015-10-23 | 0 |
DAVIES KENT J CHIEF OPERATING OFFICER |
|
16,891 | 2015-10-23 | 0 |
CONCANNON BRIAN PRESIDENT & CEO |
|
186,454 | 2015-09-15 | 0 |
ALLEN PETER M PRESIDENT, GLOBAL PLASMA |
|
34,102 | 2015-07-06 | 0 |
HELSEL DAVE EVP, GLOBAL MANUFACTURING |
|
13,216 | 2015-04-13 | 0 |
MCDANIEL KATHLEEN EVP GLOBAL HUMAN RESOURCES |
|
5,013 | 2014-08-28 | 0 |
|
10,001 | 2014-06-12 | 0 | |
KELLY MICHAEL P PRESIDENT, GLOBAL MARKETS |
|
10,987 | 2013-11-11 | 0 |
NIGHAN WARREN JR EVP, GLOBAL QA/RA |
|
7,618 | 2013-07-24 | 0 |
|
8,981 | 2013-07-24 | 0 | |
FORISH JOSEPH J VP, HUMAN RESOURCES |
|
162,747 | 2013-04-30 | 0 |
GORDON MIKAEL PRESIDENT, GLOBAL MARKETS |
|
4,442 | 2012-05-03 | 0 |
BRANCAZIO PHILLIP JOHN VP, GLOBAL MANUFACTURING |
|
38,572 | 2011-05-04 | 0 |
LOPEZ ALICIA R VP, CORPORATE AFFAIRS |
|
10,647 | 2011-04-05 | 0 |
RUXIN MICHAEL I VP GLOBAL SOFTWARE STRATEGIES |
|
215 | 2010-11-04 | 0 |
NUTTER BRAD CHAIRMAN OF THE BOARD |
|
10,580 | 2010-07-29 | 0 |
EBBELING ROBERT B VICE PRESIDENT, OPERATIONS |
|
123,405 | 2009-05-01 | 0 |
|
2,523 | 2008-06-30 | 0 | |
|
35,602 | 2008-05-01 | 0 | |
SWENSON STEPHEN VP & GENERAL MGR, GLOBAL PLASM |
|
161,364 | 2008-05-01 | 0 |
POPOVSKY MARK A VP, CORPORATE MEDICAL DIRECTOR |
|
76,463 | 2008-05-01 | 0 |
GRANVILLE WILLIAM VP, MANUFACTURING |
|
73,366 | 2008-05-01 | 0 |
HATTORI KEIKO PRESIDENT, HAEMONETICS JAPAN |
|
10,156 | 2008-05-01 | 0 |
CONNEELY JAN VP & GM, ARRYX, INC. |
|
12,840 | 2008-05-01 | 0 |
|
46,246 | 2008-05-01 | 0 | |
SAKAI RYOJI PRESIDENT, JAPAN |
|
28,373 | 2007-06-14 | 0 |
STILL WILLIAM ROCHE VP & GEN MRG, THERAPEUTICS BUS |
|
86,084 | 2007-05-01 | 0 |
RYAN RONALD J VP AND CFO |
|
83,622 | 2006-08-10 | 0 |
ECKERT ULRICH PRESIDENT, EUROPE & LATIN AM |
|
107,375 | 2006-06-20 | 0 |
|
37,000 | 2006-05-05 | 0 |
Reporting Owners | Filing Date | Trans Date | Trans Code | Shares | Share Price | Acquired Disposed |
Shares Owned after | D/I | 10b5 | Perf 1d* | Perf 5d* | Perf 1m* | Max Gain | Max Gain Days | Max Loss | Max Loss Days |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
2023-01-25 16:28:42 -0500 | 2023-01-23 | M | 2,391 | $56.57 | a | 19,625 | direct | yes | -3.0944 | 0.0 | 1 | -3.0944 | 2 | |||
2023-01-25 16:28:42 -0500 | 2023-01-23 | S | 2,391 | $90.00 | d | 17,234 | direct | yes | -3.0944 | 0.0 | 1 | -3.0944 | 2 | |||
2023-01-25 16:28:42 -0500 | 2023-01-23 | M | 2,391 | d | 7,173 | direct | yes |
* -
Code | Definition |
---|---|
A | Grant, award or other acquisition pursuant to Rule 16b-3(d) |
C | Conversion of derivative security |
D | Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) |
E | Expiration of short derivative position |
F | Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3 |
G | Bona fide gift |
H | Expiration (or cancellation) of long derivative position with value received |
I | Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities |
J | Other acquisition or disposition |
L | Small acquisition under Rule 16a-6 |
M | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 |
O | Exercise of out-of-the-money derivative security |
P | Open market or private purchase of non-derivative or derivative security |
S | Open market or private sale of non-derivative or derivative security |
U | Disposition pursuant to a tender of shares in a change of control transaction |
W | Acquisition or disposition by will or the laws of descent and distribution |
X | Exercise of in-the-money or at-the-money derivative security |
Z | Deposit into or withdrawal from voting trust |
Updated throughout the day, this shows the number of shares available to borrow. Data provided by Interactive Brokers
Security | Date/Time | Rebate Rate | Fee Rate | Shares Available |
---|---|---|---|---|
HAEMONETICS CORP-MASS HAE | 2023-01-27 22:15:03 UTC | 3.9119 | 0.4081 | 1800000 |
HAEMONETICS CORP-MASS HAE | 2023-01-27 21:45:04 UTC | 3.9119 | 0.4081 | 1800000 |
HAEMONETICS CORP-MASS HAE | 2023-01-27 21:15:04 UTC | 3.9119 | 0.4081 | 1800000 |
HAEMONETICS CORP-MASS HAE | 2023-01-27 20:45:03 UTC | 3.9119 | 0.4081 | 1800000 |
HAEMONETICS CORP-MASS HAE | 2023-01-27 20:15:04 UTC | 3.9119 | 0.4081 | 1800000 |
HAEMONETICS CORP-MASS HAE | 2023-01-27 19:45:03 UTC | 3.9119 | 0.4081 | 1800000 |
HAEMONETICS CORP-MASS HAE | 2023-01-27 19:15:03 UTC | 3.9119 | 0.4081 | 1800000 |
HAEMONETICS CORP-MASS HAE | 2023-01-27 18:45:04 UTC | 3.9119 | 0.4081 | 1800000 |
HAEMONETICS CORP-MASS HAE | 2023-01-27 18:15:03 UTC | 3.9119 | 0.4081 | 1800000 |
HAEMONETICS CORP-MASS HAE | 2023-01-27 17:45:03 UTC | 3.9119 | 0.4081 | 1800000 |
HAEMONETICS CORP-MASS HAE | 2023-01-27 17:15:04 UTC | 3.9119 | 0.4081 | 1800000 |
HAEMONETICS CORP-MASS HAE | 2023-01-27 16:45:03 UTC | 3.9212 | 0.3988 | 1800000 |
HAEMONETICS CORP-MASS HAE | 2023-01-27 16:15:03 UTC | 3.9212 | 0.3988 | 1800000 |
HAEMONETICS CORP-MASS HAE | 2023-01-27 15:45:03 UTC | 3.9212 | 0.3988 | 1900000 |
HAEMONETICS CORP-MASS HAE | 2023-01-27 15:15:04 UTC | 3.9212 | 0.3988 | 1800000 |
HAEMONETICS CORP-MASS HAE | 2023-01-27 14:45:04 UTC | 3.9212 | 0.3988 | 1800000 |
HAEMONETICS CORP-MASS HAE | 2023-01-27 14:15:03 UTC | 3.9212 | 0.3988 | 1900000 |
HAEMONETICS CORP-MASS HAE | 2023-01-27 13:45:03 UTC | 4.07 | 0.25 | 1900000 |
HAEMONETICS CORP-MASS HAE | 2023-01-27 13:15:03 UTC | 4.07 | 0.25 | 1900000 |
HAEMONETICS CORP-MASS HAE | 2023-01-27 12:45:03 UTC | 4.07 | 0.25 | 1900000 |
Holder | Issuer | Net Short Position | Position Date | Origin |
---|---|---|---|---|
AGF Investments Trust- AGFIQ U.S. Market Neutral Momentum Fund | HAE | -204.0 shares, $-24225.0 | 2020-12-31 | N-PORT |
Advisors Series Trust- Pzena Long/Short Value Fund | HAE | -1286.0 shares, $-141048.48 | 2020-05-31 | N-PORT |
FundVantage Trust- Gotham Master Neutral Fund | HAE | -23.0 shares, $-2006.75 | 2020-09-30 | N-PORT |
Guidestone Funds- Strategic Alternatives Fund | HAE | -892.0 shares, $-66034.76 | 2022-09-30 | N-PORT |
AMERICAN BEACON FUNDS- American Beacon SSI Alternative Income Fund | HAE | -2010.0 shares, $-148800.3 | 2022-09-30 | N-PORT |
AQR Funds- AQR Multi-Asset Fund | HAE | -297.0 shares, $-21986.91 | 2022-09-30 | N-PORT |
Morningstar Funds Trust- Morningstar Alternatives Fund | HAE | -2745.0 shares, $-233187.75 | 2022-10-31 | N-PORT |